The current valuation score of Lexicon Pharmaceuticals Inc is 8.54, ranking 86 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -32.35, which is -100.00% below the recent high of 0.00 and -14.29% above the recent low of -36.97.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.